GDC 0834,
GDC-0834,
GDC0834,
N-(3-(6-(4-(1,4-dimethyl-3-oxopiperazin-2-yl)phenylamino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo(b)thiophene-2-carboxamide,
GDC-0834 Racemate,
GDC-0834 (Racemate),
1133432-46-8,
GDC-0834 S-Enantiomer,
GDC-0834,
1133432-49-1,
1133432-50-4,
GDC0834 Racemate,
SCHEMBL1204020,
CDOOFZZILLRUQH-UHFFFAOYSA-N,
BCP08433,
BCP28372,
GDC-0837,
HY-15427A,
AKOS030526266,
CS-3124,
GDC 0834 Racemate;GDC0834 Racemate,
NCGC00390563-01,
N-(3-(6-((4-(1,4-dimethyl-3-oxopiperazin-2-yl)phenyl)amino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamide,
N-(3-(6-(4-(1,4-Dimethyl-3-oxopiperazin-2-yl)phenylamino)-4-methyl-5-oxo-4,5-dihydropyrazin-2-yl)-2-methylphenyl)-4,5,6,7-tetrahydrobenzo[b]thiophene-2-carboxamide,
N-[3-[6-[4-(1,4-dimethyl-3-oxopiperazin-2-yl)anilino]-4-methyl-5-oxopyrazin-2-yl]-2-methylphenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide,
N-[3-[6-[4-[(2S)-1,4-dimethyl-3-oxopiperazin-2-yl]anilino]-4-methyl-5-oxopyrazin-2-yl]-2-methylphenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide,
GDC0834,